Latest / Conversations in Lung Cancer Research
ALK TKI Sequencing in the Australian Landscape
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof Malinda Itchins to discuss the rapidly evolving landscape of Anaplastic Lymphoma Kinase (ALK) positive lung cancer. Since its discovery in 2007, treatment for this subset of non-small cell lung cancer (NSCLC) has advanced through four generations of inhibitors, significantly improving survival outcomes for the 400–500 Australians diagnosed annually.
(00:00) Welcome and Acknowledgement
(00:43) Meet the Expert Guests
(01:40) ALK History…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.